Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 2,696,648 4.500% |
-1,181,951 (-30.47%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | REGENXBIO Inc. RGNX |
Redmile Group LLC | 3,760,690 8.600% |
-477,622 (-11.27%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Repare Therapeutics Inc. RPTX |
Redmile Group LLC | 2,148,748 5.100% |
-535,648 (-19.95%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Stereotaxis, Inc. STXS |
Redmile Group LLC | 3,402,443 4.200% |
-3,695,173 (-52.06%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
Redmile Group LLC | 2,625,506 5.900% |
-1,541,469 (-36.99%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Zymeworks Inc. ZYME |
Redmile Group LLC | 5,790,230 8.300% |
-385,688 (-6.25%) |
Filing History |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
Redmile Group LLC | 10,135,388 9.900% |
1,652,066 (+19.47%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Replimune Group, Inc. REPL |
Redmile Group LLC | 4,604,483 7.400% |
-1,135,616 (-19.78%) |
Filing History |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | Scholar Rock Holding Corporation SRRK |
Redmile Group LLC | 7,706,883 9.900% |
2,205,494 (+40.09%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
Redmile Group LLC | 21,957,926 7.300% |
-6,641,568 (-23.22%) |
Filing History |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | Annexon, Inc. ANNX |
Redmile Group LLC | 8,083,776 9.900% |
3,186,201 (+65.06%) |
Filing History |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Redmile Group LLC | 412,056 9.900% |
18,557 (+4.72%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Advaxis, Inc. ADXS |
Redmile Group LLC | 211,014 1.900% |
-121,339 (-36.51%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | ImmunoGen, Inc. IMGN |
Redmile Group LLC | 16,423,922 5.900% |
-3,472,531 (-17.45%) |
Filing History |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | Neurogene Inc. NGNE |
Redmile Group LLC | 1,050,304 8.100% |
1,050,304 (New Position) |
Filing History |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Redmile Group LLC | 5,021,886 9.900% |
122,114 (+2.49%) |
Filing History |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Redmile Group LLC | 3,776,847 9.900% |
97,009 (+2.64%) |
Filing History |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Redmile Group LLC | 8,359,768 9.900% |
1,251,671 (+17.61%) |
Filing History |
| 2024-02-06 5:15 pm Purchase |
2024-02-02 | 13D | MedAvail Holdings, Inc. MDVLQ |
Redmile Group LLC | 2,490,137 73.000% |
2,490,137 (New Position) |
Filing History |
| 2024-01-31 5:15 pm Purchase |
2024-01-28 | 13D | Science 37 Holdings, Inc. SNCE |
Redmile Group LLC | 994,529 16.500% |
994,529 (New Position) |
Filing History |